<DOC>
	<DOCNO>NCT00410215</DOCNO>
	<brief_summary>Colon cleanse prior colonoscopy critically important ensure effective colonoscopy colon cancer screening , widespread North America . Currently available colon cleanse agent limit either potential safety concern significant limitation ability patient tolerate preparation . Pico-salax recently introduce Canada alternative agent use widely despite almost complete lack clinical data support efficacy safety . This study establish relative efficacy patient tolerability agent safety profile . This important , practical issue continue challenge gastroenterologist , surgeon , internist , family doctor thousand patient Canada daily basis . Anecdotal evidence suggest efficacy pico-salax used sole agent may efficacious oral sodium phosphate . Hence , hypothesis combination pico-salax bisacodyl provide efficacious bowel preparation comparison oral sodium phosphate pico-salax alone , equally well tolerate .</brief_summary>
	<brief_title>A Randomized Controlled Trial Comparing Picosalax Oral Sodium Phosphate Colon Cleansing Prior Colonoscopy</brief_title>
	<detailed_description>This randomize , investigator blind clinical trial assess cleanse efficacy ( use Ottawa Bowel Preparation scale ) tolerance three bowel cleanse regimen , two involve pico-salax .</detailed_description>
	<mesh_term>Bisacodyl</mesh_term>
	<criteria>Consecutive male nonpregnant female patient â‰¥ 18 year old require outpatient colonoscopy approach consider participation study . ileus bowel obstruction ; previous colorectal surgery ; renal impairment ; pregnancy ; recent ( &lt; 6 month ) myocardial infarction unstable angina .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>